Stay updated on Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial

Sign up to get notified when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a website transition and says agencies are using “Super Intelligence” in place of “Artificial Intelligence.” The displayed site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:26:12.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-10-06T20:10:29.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A large block of indexing terms and related metadata was removed from the study record, reducing the searchable keywords and references shown alongside the main trial details.
    Difference
    17%
    Check dated 2026-09-22T21:40:00.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.6 to v3.7.0, indicating a new version of the page or its underlying tooling.
    Difference
    0.0%
    Check dated 2026-09-15T20:38:42.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision history updated from v3.6.5 to v3.6.6, indicating a small deployment/maintenance update with no visible changes to the study details.
    Difference
    0.0%
    Check dated 2026-09-01T20:02:01.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    - NIH grant/contract attribution added to the study identifiers, placed beside the EudraCT number to reflect funding details in the record. This clarifies the funding source within the study's identifier block.
    Difference
    0.0%
    Check dated 2026-08-25T19:50:20.000Z thumbnail image

Stay in the know with updates to Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.